Deutsche Bank analyst Justin Bowers raised the firm’s price target on Bio-Techne (TECH) to $72 from $66 and keeps a Buy rating on the shares. The firm cites accretion prospects of Bio-Techne’s acquisition of Wilson Wolf for the target increase.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TECH:
- Bio-Techne announces collaboration with Wyss Center for Bio and Neuroengineering
- Bio-Techne price target raised to $68 from $65 at Argus
- Bio-Techne announces licensing agreement with Monod Bio
- Bio-Techne price target lowered to $68 from $72 at Evercore ISI
- Bio-Techne price target raised to $70 from $65 at UBS